Rumenic acid: A specific trans;L'acide ruménique: Un trans particulier

Sciences des Aliments

Volumn 28, Issue 1-2, 2008, Pages 29-33

  Martin, J C ^a,b,c  

^a INSERM   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Atherosclerosis; Cancer; Conjugated linoleic acid; Diabetes; Rumenic acid

Indexed keywords

EID: 63849192482     PISSN: 02408813     EISSN: None     Source Type: Journal    
DOI: 10.3166/sda.28.29-33     Document Type: Article

References (24)

1. AFSSA., 2005. Risques et bénéfices pour la santé des acides gras trans apportés par les aliments. Recommandations, Agence Française de Sécurité Sanitaire des Aliments.
2. A. ARO, S. MANNISTO, I. SALMINEN, et al., 2000. Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer, 38, 151-7.
3. V. CHAJES, F. LAVILLONNIERE, P. FERRARI, et al., 2002. Conjugated Linoleic Acid Content in Breast Adipose Tissue Is Not Associated with the Relative Risk of Breast Cancer in a Population of French Patients. Cancer Epidemiol Biomarkers Prev, 11, 672-673.
4. B.Q. CHEN, Y.B. XUE, J.R. LIU, et al., 2003. Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo (a) pyrene and chemopreventive mechanisms. World J Gastroenterol, 9, 44-9.
5. H. CHUJO, M. YAMASAKI, S. NOU, et al., 2003. Effect of conjugated linoleic acid isomers on growth factor-induced proliferation of human breast cancer cells. Cancer Lett, 202, 81-7.
6. E.J.HENRIKSEN, M.K.TEACHEY, Z.C. TAYLOR, et al., 2003. Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat. Am J Physiol endocrinol Metab, 285, E98-E105.
7. C. IP, S. BANNI, E. ANGIONI, G. CARTA, et al., 1999. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr, 129, 2135-2142.
8. C. JEWELL, S. CUSACK, and K.D. CASHMAN, 2005. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells. Pads Leuk Ess Fatty Acids, 72, 163-171.
9. e édition, Vol. 2, (eds. M. Rober-froid, V. Coxam and N. Delzenn), Lavoisier.
10. S.C. LARSSON, L BERGKVIST and A. WOLK, 2005. High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. Am J Clin Nutr, 82, 894-900.
11. F. LAVILLONNIERE, V. CHAJES, J.C. MARTIN, et al., 2003. Dietary purified cis-9, trans-11 conjugated linoleic acid isomer has anticarci-nogenic properties in chemically induced mammary tumors in rats. Nutr Cancer, 45, 190-4.
12. A.L. LOCK, CAM. HORNE, D.E. BAUMAN, et al., 2005. Butter Naturally Enriched in Conjugated Linoleic Acid and Vaccenic Acid Alters Tissue Fatty Acids and Improves the Plasma Lipoprotein Profile in Cholesterol-Fed Hamsters. J Nutr, 135, 1934-1939.
13. P.A. MASSO-WELCH, D. ZANGANI, C. IP, et al., 2004. Isomers of Conjugated Linoleic Acid Differ in Their Effects on Angiogenesis and Survival of Mouse Mammary Adipose Vascu-lature. J Nutr, 134, 299-307.
14. S.E. MCCANN, C. IP, M.M. IP, et al., 2004. Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev, 13, 1480-4.
15. F. MOLONEY, S. TOOMEY, E. NOONE, et al., 2007. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes, 56, 574-82.
16. M. O'SHEA, C. STANTON, and R. DEVERY, 1999. Antioxidant enzyme defence responses of human MCF-7 and SW480 cancer cells to conjugated linoleic acid. Anticancer Res, 19, 1953-9.
17. J.D. PALOMBO, A. GANGULYA, B.R. BISTRIANA, et al., 2002. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett, 177, 163-172.
18. I. PLATT, L.G. RAO, and A. EL-SOHEMY, 2007. Isomer-specific effects of conjugated linoleic acid on mineralized bone nodule formation from human osteoblast-like cells. Exp Biol Med, 232, 246-52.
19. A. ROY, A. FERLAY, K.J. SHINGFIELD, et al., 2006. Examination of the persistency of milk fatty acid composition responses to plant oils in cows given different basal diets, with particular emphasis on trans-C18:1 fatty acids and isomers of conjugated linoleic acid. Animal Science, 82, 1-15.
20. J.W. RYDER, C.P. PORTOCARRERO, X.M. SONG, et al., 2001. Isomer-specific antidia-betic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes, 50, 1149-57.
21. A.M. TURPEINEN, E. VON WILLEBRAND, I. SALMINEN, et al., 2006. Effects of cis-9, trans-11 CLA in Rats at Intake Levels. Reported for Breast-fed Infants. Lipids, 41, 669-677.
22. K. VALEILLE, J. FEREZOU, G. AMSLER, et al., 2005. A cis9, trans 11-conjugated linoleic acid rich-oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol, 289, H652-H659.
23. K. VALEILLE, J. FEREZOU, M. PARQUET, et al., 2006. The Natural Concentration of the Conjugated Linoleic Acid, cis-9, trans-11, in Milk Fat Has Antiatherogenic Effects in Hyperlipidemic Hamsters. J. Nutr., 136, 1305-1310.
24. LE. VOORRIPS, H.A. BRANTS, A.F. KARDINAAL, et al., 2002. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr, 76, 873-82.